Multiple Sclerosis News Today | Symptoms, Diagnosis, Treatments
Nov 5, 2024 · Get the latest multiple sclerosis news, patient views, and caregiver perspectives from one of the largest MS communities online.
Top 10 MS stories of 2023 - Multiple Sclerosis News Today
Jan 2, 2024 · Throughout 2023, Multiple Sclerosis News Today brought consistent coverage to our readers of the latest scientific research, developments in treatment, and clinical trials for multiple sclerosis (MS).
FDA OKs Phase 2 clinical trial of KYV-101 for progressive MS
Jan 5, 2024 · The U.S. Food and Drug Administration (FDA) has cleared a Phase 2 clinical trial to test Kyverna Therapeutics ‘ cell-based therapy candidate KYV-101 in people with treatment-resistant ...
MS prognosis and life expectancy - Multiple Sclerosis News Today
Feb 13, 2024 · But when most patients received treatment, only about 10% converted to SPMS, and over a median of 32 years. In approximately 15% of MS patients, the disease will enter a progressive phase ...
ACTRIMS 2024 - Multiple Sclerosis News Today
Multiple Sclerosis News Today is providing coverage of the ninth annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2024 Feb. 29-March 2 in West Palm Beach ...
Top 10 Multiple Sclerosis Stories of 2021
Jan 3, 2022 · Multiple Sclerosis News Today brought you daily coverage of the latest scientific research, advances in treatment, and clinical trials related to multiple sclerosis (MS) throughout 2021.
Top 10 MS Stories of 2022 - Multiple Sclerosis News Today
Dec 30, 2022 · Multiple Sclerosis News Today brought consistent coverage of the latest scientific research, developments in treatment, and clinical trials for multiple sclerosis (MS) throughout 2022.
ACTRIMS 2024: 2 treatments to aid remyelination in MS nearing...
Mar 6, 2024 · CVL-1001 inhibits EBP protein, while CVL-2001 blocks the activity of CYP51. by Marisa Wexler, MS March 6, 2024. Convelo Therapeutics is developing two experimental oral treatments to promote ...
AAN 2024: In MS study, long-term CNM-Au8 shows myelin, nerve …
by Marisa Wexler, MS April 18, 2024. Long-term treatment with Clene Nanomedicine ‘s experimental oral therapy CNM-Au8 led to signs of sustained improvements in nerve and myelin health for people ...
National MS Society awards $4.6M to 5 projects on repairing myelin
Oct 16, 2024 · by Margarida Maia, PhD October 16, 2024. The National Multiple Sclerosis Society is awarding a total of $4.6 million in funding to advance research into how the protective myelin sheath that’s ...